Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: Long-term follow-up of radiological findings

Lung Cancer

Volumn 60, Issue 2, 2008, Pages 298-301

  Soda, Hiroshi ^a,b   Nakamura, Yoichi ^a   Nakatomi, Katsumi ^a   Tomonaga, Nanae ^a   Yamaguchi, Hiroyuki ^a   Nakano, Hirofumi ^a   Nagashima, Seiji ^b   Anami, Masanobu ^c   Hayashi, Tomayoshi ^c   Tsukamoto, Kazuhiro ^d   Kohno, Sigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Computed tomography; Ground glass opacity; Lung cancer; Poorly differentiated adenocarcinoma; Solid nodule; Tumor progression

Indexed keywords

ASPARTIC PROTEINASE; NAPSIN A;

AGED; ARTICLE; BONE SCINTISCANNING; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GROUND GLASS OPACITY; HUMAN; HUMAN TISSUE; IMAGING; LONG TERM CARE; LUNG ADENOCARCINOMA; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; SOLID TUMOR; STEREOTACTIC TREATMENT; THORAX RADIOGRAPHY; TUMOR GROWTH;

ADENOCARCINOMA; AGED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42949151869     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.09.001     Document Type: Article

References (15)

1. Hirano T., Gong Y., Yoshida K., Kato Y., Yashima K., Maeda M., et al. Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer 41 (2003) 155-162
2. Aoki T., Nakata H., Watanabe H., Nakamura K., Kasai T., Hashimoto H., et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histological and tumor doubling time. Am J Roentgenol 176 (2000) 763-768
3. Takeshima S., Maruyama Y., Hasegawa M., Yamanda T., Honda T., Kadoya M., et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. Am J Roentgenol 180 (2003) 817-826
4. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Cancer 75 (1995) 2844-2852
5. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.T., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
6. Politi K., Zakowski M.F., Fan P.-D., Schonfeld E.A., Pao W., and Varmus H.E. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 20 (2006) 1496-1510
7. Ji H., Li D., Chen L., Shimamura T., Kobayashi S., McNamara K., et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 9 (2006) 485-495
8. Wislez M., Spencer M.L., Izzo J.G., Juroske D.M., Balhara K., Cody D.D., et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 65 (2005) 3226-3235
9. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15 (2001) 3243-3248
10. Yoshida Y., Shibata T., Kokubu A., Tsuta K., Matsuno Y., Kanai Y., et al. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 50 (2005) 1-8
11. Sakamoto H., Shimizu J., Horio Y., Ueda R., Takahashi T., Mitsudomi T., et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinoma. J Pathol 212 (2007) 287-294
12. Nakano H, Soda H, Takasu M, Tomonaga N, Yamaguchi H, Nakatomi K, et al. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule. Lung Cancer (in press).
13. Kakinuma R., Ohmatsu H., Kaneko M., Kusumoto M., Yoshida J., Nagai K., et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 28 (2004) 17-23
14. Haneda H., Sasaki H., Shimizu S., Endo K., Suzuki E., Yukiue H., et al. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer 52 (2006) 47-52
15. Wiseman S.M., Loree T.R., Rigual N.R., Hicks Jr. W.L., Douglas W.G., Anderson G.R., et al. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25 (2003) 662-670